They may have a fair idea from the progression of the trial phase but they will probably still need to collate the data and formally present their analysis.
I would love for it to be favourable to the science of A2 vs A1.
However, to be fair, I hope it is a definitive conclusion, backed with solid evidence.
Whatever the result.
They may have a fair idea from the progression of the trial...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.50 |
Change
-0.035(0.63%) |
Mkt cap ! $3.953B | |||
| Open | High | Low | Value | Volume |
| $5.47 | $5.50 | $5.45 | $1.553M | 283.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 24618 | $5.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.50 | 33551 | 22 |
View Market Depth
| Last trade - 11.45am 04/09/2024 (20 minute delay) ? |
| A2M (ASX) Chart |